Aralen Trademark Details

Aralen was registered on Tuesday, March 14, 1961 and is currently owned by Sanofi-Aventis U.S. LLC under the registration number 712412 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 14 years ago on Wednesday, February 16, 2011, according to the United State Patent & Trademark Office
Word Mark Aralen
Status Alive Registered 800 — Registered and Renewed

Previous Owners

Sanofi-Synthelabo Inc. of New York, NY

View all trademarks for Sanofi-Synthelabo Inc.
Other Trademarks for Sanofi-Synthelabo Inc.

Sterling Drug Inc. of New York, NY

View all trademarks for Sterling Drug Inc.
Other Trademarks for Sterling Drug Inc.
Serial Number 72102434
Registration Number 712412
Status Date Wednesday, February 16, 2011
Filing Date Wednesday, February 16, 2011
Registration Date Tuesday, March 14, 1961
Attorney Susan Upton Douglass
Domestic Representative Diane Donnelly, Esq.

Correspondent

SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLAZA
NEW YORK NY 10017

Case File Statements

Goods & Services Preparation for the Treatment of Malaria [, Rheumatoid Arthritis, Light Sensitivity Skin Eruptions, Such as Lupus Erythematosus, and Other Similar Conditions]

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 6 — Active
Status Date Tuesday, November 2, 1999
First Use Anywhere Friday, March 8, 1946
First Use In Commerce Friday, March 8, 1946
Primary Code 018

You must be signed in to print.

Once signed in, look for the PDF button.